Science Explorer Back to mapMap
Discussion
Company · Ivrea · Italy

Resis (Italy)

Research works
1
▼ 90% vs 2018-21
Citations
29
23.4 per fractional work
Top-10% rate
36.4%
all institutions 10.0%
Open access
46%
world 40%
International
100%
world 18%

Not ranked overall: Resis (Italy) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Resis (Italy) work in?

In all years, 54% of research at Resis (Italy) is in Life Sciences, 31% in Health Sciences. Its largest fields are Agricultural and Biological Sciences (54%), Medicine (31%), Social Sciences (15%).

Life Sciences54%Health Sciences31%Social Sciences15%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 3 fields, with their numbers
    1. Agricultural and Biological Sciences153.8%
    1. Medicine030.8%
    1. Social Sciences015.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Resis (Italy)?

The most cited paper from Resis (Italy) is "COVID-19 infection: the perspectives on immune responses" (Yufang Shi, Ying Wang, Changshun Shao et al., 2020), with 1,687 citations. Next come "Safety and efficacy of the Russian COVID-19 vaccine: more information needed" (85) and "BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?" (64).

Most cited papers
#PaperReleasedCitations
1 COVID-19 infection: the perspectives on immune responses Yufang Shi, Ying Wang, Changshun Shao et al. · Cell Death and Differentiation Open access 23 Mar 2020 1,687
2 Safety and efficacy of the Russian COVID-19 vaccine: more information needed Enrico M Bucci, Konstantin Andreev, Anders Björkman et al. · The Lancet Open access 21 Sep 2020 85
3 BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic? Abhibhav Sharma, Saurabh Kumar Sharma, Yufang Shi et al. · Cell Death and Disease Open access 8 Jul 2020 64
4 Xylella fastidiosa , a new plant pathogen that threatens global farming: Ecology, molecular biology, search for remedies Enrico M Bucci · Biochemical and Biophysical Research Communications 7 Jun 2018 39
5 A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia Giovanni Landoni, Lorenzo Piemonti, Antonella d’Arminio Monforte et al. · Infectious Diseases and Therapy Open access 26 May 2022 25
All 6 most cited papers, with filters and sorting

Which research topics does Resis (Italy) publish most on?

By volume in 2022-now: Respiratory Support and Mechanisms, Long-Term Effects of COVID-19 and COVID-19 Clinical Research Studies.

  1. 1 Respiratory Support and Mechanisms Pulmonary and Respiratory Medicine 0 works
  2. 2 Long-Term Effects of COVID-19 Neurology 0 works
  3. 3 COVID-19 Clinical Research Studies Infectious Diseases 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.1%not open53.9%

World: 40% of research is openly available.

with international co-authors100.0%

World: 18% is written across borders.

How has Resis (Italy)'s research output changed?

Output in 2022-2025 was 90% lower than in 2018-2021.

2020

Other research institutions in Ivrea

All research institutions in Ivrea

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Resis (Italy). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.